Intracranial angiomatoid fibrous histiocytoma presenting as recurrent multifocal intraparenchymal hemorrhage.

Recurrent Painful Perianal Subcutaneous Angiomatoid Fibrous Histiocytoma

Angiomatoid fibrous histiocytoma (AFH) is a rare, lowgrade malignant soft-tissue tumor most commonly occurring in the extremities of children and young adults and has a low potential of local recurrence and metastasis. Here, we present a case of recurrent subcutaneous perianal AFH. After an initial diagnosis as a sebaceous cyst, we were able to use immunohistochemical findings to correctly iden...

Subcutaneous Angiomatoid Fibrous Histiocytoma Mimicking Metastatic Melanoma

Angiomatoid fibrous histiocytoma is an uncommon soft-tissue tumor of intermediate malignancy that is often misdiagnosed initially. As there is not one immunohistochemical marker that consequently stains positive or negative for angiomatoid fibrous histiocytoma, molecular diagnostics are becoming more widely used. So far three translocations have been reported to arise in angiomatoid fibrous his...

Clinicopathological features of angiomatoid fibrous histiocytoma: a series of 21 cases with variant morphology.

We analyzed the clinicopathological features of angiomatoid fibrous histiocytoma (AFH) in 21 cases with emphasis on variant morphology. In our series, ten patients were male and eleven were female. The patients' mean age was 26.9 years old. Tumors were located on the lower limbs in eight cases, upper limbs in three, trunk in five, head and neck in four, and trachea in one. Microscopically, thir...

Cervical Angiomatoid Fibrous Histiocytoma

Background: Angiomatoid fibrous histiocytoma (AFH) is a rare type of sarcoma with low-grade malignancy that usually occurs in young subjects. AFH is uncommon in the head and neck region. Methods: We describe an exceptional case of localization in the neck. This is the first report of a rare variant of AFH presenting in a 42-year-old woman. The tumor was situated posterior to the carotid artery ...

A simple Baker's cyst? Tocilizumab remits paraneoplastic signs and controls growth of IL-6-producing angiomatoid malignant fibrous histiocytoma